Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease

Cited by (1,004)

Items 401–500 of 1,004

1. PARK7/DJ-1 in microglia: implications in Parkinson’s disease and relevance as a therapeutic target
   Frida Lind‐Holm Mogensen, Andrea Scafidi, Aurélie Poli, Alessandro Michelucci · 2023 · Journal of Neuroinflammation
2. The G2019S LRRK2 mutation increases myeloid cell chemotactic responses and enhances LRRK2 binding to actin-regulatory proteins
   Mark S. Moehle, João Paulo Lima Daher, Travis D. Hull, Ravindra Boddu, Hisham Abdelmotilib, James A. Mobley, George T. Kannarkat, Malú G. Tansey, Andrew B. West · 2015 · Human Molecular Genetics
3. Genetic risk and age in Parkinson's disease: Continuum not stratum
   Mike A. Nalls, Valentina Escott‐Price, Nigel M. Williams, Steven J Lubbe, Margaux F. Keller, Huw R. Morris, Andrew Singleton · 2015 · Movement Disorders
4. Impact of physiological, pathological and environmental factors on the expression and activity of human cytochrome P450 2D6 and implications in precision medicine
   Zhi-Xu He, Xiao-Wu Chen, Zhi-Wei Zhou, Shu-Feng Zhou · 2015 · Drug Metabolism Reviews
5. Pro-cathepsin D, Prosaposin, and Progranulin: Lysosomal Networks in Parkinsonism
   Nahid Tayebi, Grisel J. Lopez, Jenny Do, Ellen Sidransky · 2020 · Trends in Molecular Medicine
6. Genomics and Functional Genomics of Alzheimer's Disease
   Kamboh, M. Ilyas · 2022 · Neurotherapeutics
7. Clinical subtypes and genetic heterogeneity: of lumping and splitting in Parkinson disease
   Rainer von Coelln, Lisa M. Shulman · 2016 · Current Opinion in Neurology
8. Increased brain expression of GPNMB is associated with genome wide significant risk for Parkinson’s disease on chromosome 7p15.3
   UKBEC, Megha N. Murthy, IPDGC, Cornelis Blauwendraat, Sebastian Guelfi, John Hardy, Patrick Alfryn Lewis, Daniah Trabzuni · 2017 · Neurogenetics
9. Connecting Metainflammation and Neuroinflammation Through the PTN-MK-RPTPβ/ζ Axis: Relevance in Therapeutic Development
   Gonzalo Herradón, Pilar Ramos, Esther Gramage · 2019 · Frontiers in Pharmacology
10. The role of lipids in α-synuclein misfolding and neurotoxicity
    Cathryn L. Ugalde, Victoria Lawson, David Isaac Finkelstein, Andrew Francis Hill · 2019 · Journal of Biological Chemistry
11. Putamen gray matter volumes in neuropsychiatric and neurodegenerative disorders.
    Xingguang Luο, Qiao Mao, Jing Shi, Xiaoping Wang, Chiang‐Shan R. Li · 2019 · PubMed
12. Blood and Cerebrospinal Fluid Biomarkers of Inflammation in Parkinson’s Disease
    Milan Zimmermann, Kathrin Brockmann · 2022 · Journal of Parkinson s Disease
13. The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders
    Margrethe A. Olesen, Francisca Villavicencio-Tejo, Rodrigo A. Quintanilla · 2022 · Translational Neurodegeneration
14. The relationship of alpha-synuclein to mitochondrial dynamics and quality control
    Naomi J. Thorne, David A. Tumbarello · 2022 · Frontiers in Molecular Neuroscience
15. Genetic Profile, Environmental Exposure, and Their Interaction in Parkinson’s Disease
    Letizia Polito, Antonio Greco, Davide Seripa · 2016 · Parkinson s Disease
16. Impact of Parkinson's disease risk loci on age at onset
    Christina M. Lill, Johnni Hansen, Jørgen H. Olsen, Harald Binder, Beate R. Ritz, Lars Bertram · 2015 · Movement Disorders
17. The Parkinson's Disease Mendelian Randomization Research Portal
    Alastair John Noyce, Sara Bandrés‐Ciga, Jonggeol Kim, Karl Heilbron, Demis A. Kia, Gibran Hemani, Angli Xue, Debbie A. Lawlor, George Davey Smith, Raquel Durán et al. · 2019 · Movement Disorders
18. Stress-Induced Cellular Clearance Is Mediated by the SNARE Protein ykt6 and Disrupted by α-Synuclein
    Leah K. Cuddy, Willayat Yousuf Wani, Martino L. Morella, Caleb Pitcairn, Kotaro Tsutsumi, Kristina Fredriksen, Craig J. Justman, Tom N. Grammatopoulos, Nandkishore R. Belur, Friederike Zunke et al. · 2019 · Neuron
19. Genetic perspective on the synergistic connection between vesicular transport, lysosomal and mitochondrial pathways associated with Parkinson’s disease pathogenesis
    Stefanie Smolders, Christine Van Broeckhoven · 2020 · Acta Neuropathologica Communications
20. Fine mapping of the HLA locus in Parkinson’s disease in Europeans
    Eric Yu, Aditya Ambati, Maren Stolp Andersen, Lynne Krohn, Mehrdad A. Estiar, Prabhjyot Saini, Konstantin A. Senkevich, Yuri Ludwig Sosero, Ashwin Ashok Kumar Sreelatha, Jennifer A. Ruskey et al. · 2021 · npj Parkinson s Disease
21. Discovery of genomic loci of the human cerebral cortex using genetically informed brain atlases
    Carolina Makowski, Dennis van der Meer, Weixiu Dong, Hao Wang, Yan Wu, Jingjing Zou, Cin Liu, Sara B. Rosenthal, Donald J. Hagler, Chun Chieh Fan et al. · 2022 · Science
22. Genomic Enhancers in Brain Health and Disease
    Nancy V. N. Carullo, Jeremy J. Day · 2019 · Genes
23. Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity
    An Phu Tran Nguyen, Elpida Tsika, Kaela Kelly, Nathan D. Levine, Xi Chen, Andrew B. West, Sylviane Boularand, Pascal Barnéoud, Darren J. Moore · 2020 · Proceedings of the National Academy of Sciences
24. Parkinson’s disease updates: Addressing the pathophysiology, risk factors, genetics, diagnosis, along with the medical and surgical treatment
    Priyadarshi Prajjwal, Herson S Flores Sanga, Kirtish Acharya, Tamara Tango, Jobby John, Rene S.C. Rodriguez, Mohammed Dheyaa Marsool Marsool, Mukhamed Sulaimanov, Aneeqa Ahmed, Omniat Amir Hussin · 2023 · Annals of Medicine and Surgery
25. Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease
    Kamil Saramowicz, Natalia Siwecka, Grzegorz Galita, Aleksandra Kucharska-Lusina, Wioletta Rozpędek‐Kamińska, Ireneusz Majsterek · 2023 · International Journal of Molecular Sciences
26. Protective efficacy of phosphodiesterase-1 inhibition against alpha-synuclein toxicity revealed by compound screening in LUHMES cells
    Matthias Höllerhage, Claudia Moebius, Johannes C. Melms, Wei‐Hua Chiu, Joachim Nils Goebel, Tasnim Chakroun, Thomas Koeglsperger, Wolfgang H. Oertel, Thomas W. Rösler, Marc Bickle et al. · 2017 · Scientific Reports
27. Intergenic disease-associated regions are abundant in novel transcripts
    Nenad Bartoniček, Michael B. Clark, Xiu Cheng Quek, James Torpy, Antonia L. Pritchard, Jesper L.V. Mååg, Brian Gloss, Joanna Crawford, Ryan J. Taft, Nicholas K. Hayward et al. · 2017 · Genome biology
28. The Emerging Functions of LRRK2 and Rab GTPases in the Endolysosomal System
    Tomoki Kuwahara, Takeshi Iwatsubo · 2020 · Frontiers in Neuroscience
29. MIR-NATs repress MAPT translation and aid proteostasis in neurodegeneration
    Roberto Simone, Faiza Javad, Warren Emmett, Oscar G. Wilkins, Filipa Almeida, Natalia Barahona‐Torres, Justyna Zarȩba-Pasławska, Mazdak Ehteramyan, Paola Zuccotti, Angelika Modelska et al. · 2021 · Nature
30. Deregulation of α-synuclein in Parkinson’s disease: Insight from epigenetic structure and transcriptional regulation of SNCA
    Subhrangshu Guhathakurta, Eugene Bok, Baggio Evangelista, Yoon‐Seong Kim · 2017 · Progress in Neurobiology
31. An integrated transcriptomics and proteomics analysis reveals functional endocytic dysregulation caused by mutations in LRRK2
    Natalie Connor‐Robson, Heather Booth, Jeffrey G. Martin, Benbo Gao, Kejie Li, Natalie M. Doig, Jane Vowles, Cathy Browne, Laura Klinger, Péter Juhász et al. · 2019 · Neurobiology of Disease
32. Insights from late-onset familial parkinsonism on the pathogenesis of idiopathic Parkinson's disease
    Mattia Volta, Austen J. Milnerwood, Matthew James Farrer · 2015 · The Lancet Neurology
33. Genotype-Phenotype Correlations in Monogenic Parkinson Disease: A Review on Clinical and Molecular Findings
    Daniele Guadagnolo, Maria Piane, Maria Rosaria Torrisi, Antonio Pizzuti, Simona Petrucci · 2021 · Frontiers in Neurology
34. Integrating whole-genome sequencing with multi-omic data reveals the impact of structural variants on gene regulation in the human brain
    Ricardo A. Vialle, Kátia de Paiva Lopes, David Alan Bennett, John F. Crary, Towfique Raj · 2022 · Nature Neuroscience
35. Fractalkine Signaling Regulates the Inflammatory Response in an α-Synuclein Model of Parkinson Disease
    Aaron D. Thome, David G. Standaert, Ashley S. Harms · 2015 · PLoS ONE
36. S tudy of LRRK2 variation in tauopathy: Progressive supranuclear palsy and corticobasal degeneration
    Mónica Sánchez-Contreras, Michael G. Heckman, Pawel M. Tacik, Nancy N. Diehl, Patricia H. Brown, Alexandra I. Soto‐Ortolaza, Elizabeth A. Christopher, Ronald L. Walton, Owen A. Ross, Lawrence I. Golbe et al. · 2016 · Movement Disorders
37. Neuromicrobiology: How Microbes Influence the Brain
    César de la Fuente‐Núñez, Beatriz T. Meneguetti, Octávio Luiz Franco, Timothy K. Lu · 2017 · ACS Chemical Neuroscience
38. G2019S LRRK2 mutation facilitates α-synuclein neuropathology in aged mice
    Salvatore Novello, Ludovico Arcuri, Sandra Doveró, Nathalie Dutheil, Derya R. Shimshek, Erwan Bézard, Michele Morari · 2018 · Neurobiology of Disease
39. Endogenous Rab29 does not impact basal or stimulated LRRK2 pathway activity
    Alexia F. Kalogeropulou, Jordana B. Freemantle, Paweł Lis, Edmundo G. Vides, Nicole K. Polinski, Dario R. Alessi · 2020 · Biochemical Journal
40. Organophosphate Pesticide Exposures, Nitric Oxide Synthase Gene Variants, and Gene–Pesticide Interactions in a Case–Control Study of Parkinson’s Disease, California (USA)
    Kimberly C. Paul, Janet S. Sinsheimer, Shannon L. Rhodes, Myles Cockburn, Jeff M. Bronstein, Beate R. Ritz · 2015 · Environmental Health Perspectives
41. Alpha-Synuclein and Lipids: The Elephant in the Room?
    Alessia Sarchione, Antoine Marchand, Jean‐Marc Taymans, Marie‐Christine Chartier‐Harlin · 2021 · Cells
42. Prion-like Propagation of α-Synuclein Is Regulated by the FcγRIIB-SHP-1/2 Signaling Pathway in Neurons
    Yu Ree Choi, Seon‐Heui Cha, Seo‐Jun Kang, Jae-Bong Kim, Ilo Jou, Sang Myun Park · 2018 · Cell Reports
43. Divergent Effects of Metformin on an Inflammatory Model of Parkinson’s Disease
    Khadija Tayara, Ana M. Espinosa‐Oliva, Irene García-Domínguez, Afrah Abdul Ismaiel, Antonio Boza‐Serrano, Tomas Deierborg, Alberto Machado, Antonio J. Herrera, Jose Luis Venero, Rocío M. de Pablos · 2018 · Frontiers in Cellular Neuroscience
44. Genetic variability and potential effects on clinical trial outcomes: perspectives in Parkinson’s disease
    Hampton L. Leonard, Cornelis Blauwendraat, Lynne Krohn, Faraz Faghri, Hirotaka Iwaki, G. D. Ferguson, Aaron Day-Williams, David J. Stone, Andrew Singleton, Mike A. Nalls et al. · 2019 · Journal of Medical Genetics
45. Identifying Therapeutic Agents for Amelioration of Mitochondrial Clearance Disorder in Neurons of Familial Parkinson Disease
    Akihiro Yamaguchi, Kei‐ichi Ishikawa, Tsuyoshi Inoshita, Kahori Shiba‐Fukushima, Shinji Saiki, Taku Hatano, Akio Mori, Yutaka Oji, Ayami Okuzumi, Yuanzhe Li et al. · 2020 · Stem Cell Reports
46. Non-genetic risk and protective factors and biomarkers for neurological disorders: a meta-umbrella systematic review of umbrella reviews
    Alexios‐Fotios A. Mentis, Efthimios Dardiotis, Vasiliki Efthymiou, George Panagiotis Chrousos · 2021 · BMC Medicine
47. Gut Metabolites Acting on the Gut-Brain Axis: Regulating the Functional State of Microglia
    Wenze Deng, Pengcheng Yi, Yanhong Xiong, Jun Ying, Yue Lin, Yao Dong, Gen Wei, Xifeng Wang, Fuzhou Hua · 2023 · Aging and Disease
48. Tracking Parkinson’s: Study Design and Baseline Patient Data
    Naveed Malek, Diane M.A. Swallow, Katherine A. Grosset, Michael Lawton, Sarah L. Marrinan, Alexander Lehn, Catherine Bresner, Nin P.S. Bajaj, Roger A. Barker, Yoav Ben‐Shlomo et al. · 2015 · Journal of Parkinson s Disease
49. Epigenome-wide DNA methylation analysis in siblings and monozygotic twins discordant for sporadic Parkinson’s disease revealed different epigenetic patterns in peripheral blood mononuclear cells
    Oliver Kaut, Ina Schmitt, Jörg Tost, Florence Busato, Yi Liu, Per Hofmann, Stephanie H. Witt, Marcella Rietschel, Holger Fröhlich, Ullrich Wüllner · 2016 · Neurogenetics
50. The 200-year journey of Parkinson disease: Reflecting on the past and looking towards the future
    Stanley Fahn · 2017 · Parkinsonism & Related Disorders
51. Machine Learning–Based Gene Prioritization Identifies Novel Candidate Risk Genes for Inflammatory Bowel Disease
    Ofer Isakov, Iris Dotan, Shay Ben‐Shachar · 2017 · Inflammatory Bowel Diseases
52. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale
    Nicolas Ruffini, Susanne Klingenberg, Susann Schweiger, Susanne Gerber · 2020 · Cells
53. Ceramide Metabolism and Parkinson’s Disease—Therapeutic Targets
    Antía Custodia, Marta Aramburu-Núñez, Clara Correa‐Paz, Adrián Posado-Fernández, Ana Gómez-Larrauri, José Castillo, Antonio Gómez‐Muñoz, Tomás Sobrino, Alberto Ouro · 2021 · Biomolecules
54. PIAS2-mediated blockade of IFN-β signaling: a basis for sporadic Parkinson disease dementia
    Joana Magalhães, Emilie Tresse, Patrick Ejlerskov, Erling Hu, Yawei Liu, Andrea Marín, Alexia Montalant, Letizia Satriano, Carsten F. Rundsten, Eva Meier Carlsen et al. · 2021 · Molecular Psychiatry
55. Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson disease
    Laura J. Smith, Chiao‐Yin Lee, Elisa Menozzi, Anthony H.V. Schapira · 2022 · Frontiers in Neurology
56. Gene-environment interactions linking air pollution and inflammation in Parkinson's disease
    Pei‐Chen Lee, Ole Raaschou‐Nielsen, Christina M. Lill, Lars Bertram, Janet S. Sinsheimer, Johnni Hansen, Beate R. Ritz · 2016 · Environmental Research
57. Parkinson’s Disease Biomarkers: Perspective from the NINDS Parkinson’s Disease Biomarkers Program
    Katrina A. Gwinn, Karen Kate David, Christine Swanson‐Fischer, Roger L. Albin, Coryse St. Hillaire‐Clarke, Beth-Anne Sieber, Codrin Lungu, F. DuBois Bowman, Roy N. Alcalay, Debra Babcock et al. · 2017 · Biomarkers in Medicine
58. Drosophila Models of Sporadic Parkinson’s Disease
    Emi Nagoshi · 2018 · International Journal of Molecular Sciences
59. DNAJC proteins and pathways to parkinsonism
    Dorien A. Roosen, Cornelis Blauwendraat, Mark Cookson, Patrick Alfryn Lewis · 2019 · FEBS Journal
60. Exosome release and neuropathology induced by α-synuclein: new insights into protective mechanisms of Drp1 inhibition
    Rebecca Zhangqiuzi Fan, Min Amy Guo, Shouqing Luo, Mei Cui, Kim Tieu · 2019 · Acta Neuropathologica Communications
61. PET imaging of colony-stimulating factor 1 receptor: A head-to-head comparison of a novel radioligand, 11 C-GW2580, and 11 C-CPPC, in mouse models of acute and chronic neuroinflammation and a rhesus monkey
    Xiaoyun Zhou, Bin Ji, Chie Seki, Yuji Nagai, Takafumi Minamimoto, Masayuki Fujinaga, Ming‐Rong Zhang, Takashi Saito, Takaomi C. Saido, Tetsuya Suhara et al. · 2021 · Journal of Cerebral Blood Flow & Metabolism
62. Microglia and astrocyte activation is region‐dependent in the α‐synuclein mouse model of Parkinson's disease
    Leyre Basurco, Miguel Angel Abellanas, Leyre Ayerra, Enrique Conde, Rodrigo Vinueza‐Gavilanes, Esther Luquin, África Vales, Amaya Vilas, Patxi San Martín‐Úriz, Ibón Tamayo et al. · 2022 · Glia
63. Polygenic determinants of Parkinson's disease in a Chinese population
    Jifeng Guo, Kai Li, Ri-li Yu, Qi-Yin Sun, Lei Wang, Lingyan Yao, Yacen Hu, Zhanyun Lv, Lin-zi Luo, Lu Hua Shen et al. · 2015 · Neurobiology of Aging
64. C. elegans as a model system to accelerate discovery for Parkinson disease
    Bryan Martinez, Kim A. Caldwell, Guy A. Caldwell · 2017 · Current Opinion in Genetics & Development
65. Parkinson's disease-associated genetic variation is linked to quantitative expression of inflammatory genes
    Steven E. Pierce, Gerhard A. Coetzee · 2017 · PLoS ONE
66. Mammalian TRIM67 Functions in Brain Development and Behavior
    Nicholas P. Boyer, Caroline Monkiewicz, Shalini Menon, Sheryl S. Moy, Stephanie L. Gupton · 2018 · eNeuro
67. Role of VPS13, a protein with similarity to ATG2, in physiology and disease
    Ugur, Berrak, Hancock-Cerutti, William, Leonzino, Marianna, De Camilli, Pietro · 2020 · Current Opinion in Genetics & Development
68. CHCHD2 and Parkinson's disease
    Iris E. Jansen, José Brás, Suzanne Lesage, Claudia Schulte, Jesse Raphael Gibbs, Mike A. Nalls, Alexis Brice, Nicholas William Wood, Huw R. Morris, John Hardy et al. · 2015 · The Lancet Neurology
69. The importance of preclinical diagnostics in Parkinson disease
    Sneha Mantri, James F. Morley, Andrew D. Siderowf · 2018 · Parkinsonism & Related Disorders
70. Age-associated insolubility of parkin in human midbrain is linked to redox balance and sequestration of reactive dopamine metabolites
    Jacqueline M. Tokarew, Daniel N. El Kodsi, Nathalie A. Lengacher, Travis K. Fehr, Angela Nguyen, Bojan Shutinoski, Brian O’Nuallain, Ming Jin, Jasmine M. Khan, Andy Cheuk‐Him Ng et al. · 2021 · Acta Neuropathologica
71. "Metal elements and pesticides as risk factors for Parkinson's disease - A review"
    Inam Ullah, Longhe Zhao, Hai Tao Yang, Fahim Muhammad, Dhafer Alwayli, Xin Wang, Hongyu Li · 2021 · Toxicology Reports
72. Brain and Systemic Inflammation in De Novo Parkinson's Disease
    Talene A. Yacoubian, Yu-Hua Dean Fang, Adam T. Gerstenecker, Amy W. Amara, Natividad P. Stover, Lauren Ruffrage, Christopher Collette, Richard Kennedy, Yue Zhang, Huixian Hong et al. · 2023 · Movement Disorders
73. Leucine-rich repeat kinase 2 (LRRK2) regulates α-synuclein clearance in microglia
    Maekawa, Tatsunori, Sasaoka, Toshikuni, Azuma, Sadahiro, Ichikawa, Takafumi, Melrose, Heather L., Farrer, Matthew J., Obata, Fumiya · 2016 · BMC Neuroscience
74. Transcriptomic and genetic analyses reveal potential causal drivers for intractable partial epilepsy
    Sebastian Guelfi, Juan Antonio Botía, Maria Thom, Adaikalavan Ramasamy, Marina Perona, Lee Stanyer, Lillian Martinian, Daniah Trabzuni, Colin Smith, ROBERT E. WALKER et al. · 2019 · Brain
75. Joint-Connectivity-Based Sparse Canonical Correlation Analysis of Imaging Genetics for Detecting Biomarkers of Parkinson’s Disease
    Mansu Kim, Ji Hye Won, Jinyoung Youn, Hyunjin Park · 2019 · IEEE Transactions on Medical Imaging
76. Reformulating Pro-Oxidant Microglia in Neurodegeneration
    Juan García‐Revilla, Isabel María Alonso-Bellido, Miguel Ángel Burguillos, Antonio J. Herrera, Ana M. Espinosa‐Oliva, Rocío Ruiz, Luis Cruz-Hernández, Irene García-Domínguez, María Angustias Roca-Ceballos, Marti Santiago et al. · 2019 · Journal of Clinical Medicine
77. T-cell dysregulation is associated with disease severity in Parkinson’s Disease
    Divisha Bhatia, Veselin Grozdanov, Wolfgang Philipp Ruf, Jan Kassubek, Albert C. Ludolph, Jochen Hans Weishaupt, Karin M. Danzer · 2021 · Journal of Neuroinflammation
78. T Lymphocytes in Parkinson’s Disease
    Elena Contaldi, Luca Magistrelli, Cristoforo Comi · 2022 · Journal of Parkinson s Disease
79. Biomarkers in Parkinson’s disease: A state of the art review
    Kyla Y. Yamashita, Sweta Bhoopatiraju, Bret Silverglate, George Thomas Grossberg · 2023 · Biomarkers in Neuropsychiatry
80. Ten Y ears and C ounting: M oving L eucine‐ R ich Repeat K inase 2 I nhibitors to the C linic
    Andrew B. West · 2014 · Movement Disorders
81. Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges
    Bin Xiao, Huck‐Hui Ng, Ryōsuke Takahashi, Eng-King Tan · 2016 · Journal of Neurology Neurosurgery & Psychiatry
82. The Genetic Basis of Cognitive Impairment and Dementia in Parkinson’s Disease
    Lucy Collins, Caroline H. Williams‐Gray · 2016 · Frontiers in Psychiatry
83. Clinical Amyloid Imaging
    Atul K. Mallik, Alexander E. Drzezga, Satoshi Minoshima · 2016 · Seminars in Nuclear Medicine
84. Genetic pleiotropy between age-related macular degeneration and 16 complex diseases and traits
    Felix Graßmann, Christina Kiel, Martina E. Zimmermann, Mathias Gorski, Veronika Grassmann, Klaus J. Stark, Iris M. Heid, Bernhard H. F. Weber · 2017 · Genome Medicine
85. MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment.
    Mélanie Bérubé, A. Deschambeault, Maryse Boucher, Lucie Germain, Éric Petitclerc, Sylvain L. Guérin · 2005 · PubMed
86. A Druggable Genome Screen Identifies Modifiers of α-Synuclein Levels via a Tiered Cross-Species Validation Approach
    Rousseaux, Maxime W.C., Vázquez-Vélez, Gabriel E., Al-Ramahi, Ismael, Jeong, Hyun-Hwan, Bajić, Aleksandar, Revelli, Jean-Pierre, Ye, Hui, Phan, Emily T., Deger, Jennifer M., Perez, Alma M. et al. · 2018 · The Journal of Neuroscience
87. Gaucher disease: Basic and translational science needs for more complete therapy and management
    Gregory Alex Grabowski, Armand H. Matheny Antommaria, Edwin H. Kolodny, Pramod Kumar Mistry · 2020 · Molecular Genetics and Metabolism
88. Glucocerebrosidase mutations and Parkinson disease
    Sophia R.L. Vieira, Anthony H.V. Schapira · 2022 · Journal of Neural Transmission
89. Dopamine transporter and synaptic vesicle sorting defects underlie auxilin-associated Parkinson’s disease
    D. J. Vidyadhara, Mahalakshmi Somayaji, Nigel Wade, Betül Yücel, Helen R. Zhao, N Shashaank, Joseph Ribaudo, Jyoti Gupta, TuKiet T. Lam, Dalibor Sameš et al. · 2023 · Cell Reports
90. Multisystem Lewy body disease and the other parkinsonian disorders
    J. William Langston, Birgitt Schüle, Linda Rees, R. Jeremy Nichols, Carrolee Barlow · 2015 · Nature Genetics
91. Additional rare variant analysis in Parkinson’s disease cases with and without known pathogenic mutations: Evidence for oligogenic inheritance
    Lubbe, Steven J., Escott-Price, Valentina, Gibbs, J. Raphael, Nalls, Mike A., Bras, Jose, Price, T. Ryan, Nicolas, Aude, Jansen, Iris E., Mok, Kin Y., Pittman, Alan M. et al. · 2016 · Human Molecular Genetics
92. Mechanisms of LRRK2-dependent neurodegeneration: role of enzymatic activity and protein aggregation
    Md. Shariful Islam, Darren J. Moore · 2017 · Biochemical Society Transactions
93. Genome-wide meta-analysis and replication studies in multiple ethnicities identify novel adolescent idiopathic scoliosis susceptibility loci
    Anas M. Khanshour, Ikuyo Kou, Yanhui Fan, Elísabet Einarsdóttir, Nadja Makki, Yared H. Kidane, Juha Kere, Anna Grauers, Todd A. Johnson, Nandina Paria et al. · 2018 · Human Molecular Genetics
94. Structural basis for ion selectivity in TMEM175 K+ channels
    Janine Denise Brunner, Roman Peter Jakob, Tobias Schulze, Yvonne Neldner, Anna Moroni, Gerhard Thiel, Timm Maier, Stephan Schenck · 2020 · eLife
95. Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson’s disease at 16q11.2 and MAPT H1 loci
    Marc P. M. Soutar, Daniela Melandri, Benjamin O’Callaghan, Emily Annuario, Amy E. Monaghan, Natalie J. Welsh, Karishma D’Sa, Sebastian Guelfi, David Zhang, Alan Michael Pittman et al. · 2022 · Brain
96. More than meets the eye in Parkinson’s disease and other synucleinopathies: from proteinopathy to lipidopathy
    Manuel Flores‐León, Tiago F. Outeiro · 2023 · Acta Neuropathologica
97. Lysosomal trafficking defects link Parkinson's disease with Gaucher's disease
    Yvette C. Wong, Dimitri Krainc · 2016 · Movement Disorders
98. The LRRK2–macroautophagy axis and its relevance to Parkinson's disease
    Claudia Manzoni · 2017 · Biochemical Society Transactions
99. Genetic Variants in SNCA and the Risk of Sporadic Parkinson’s Disease and Clinical Outcomes: A Review
    Clarissa Loureiro das Chagas Campêlo, Regina H. Silva · 2017 · Parkinson s Disease
100. A comprehensive analysis of SNCA ‐related genetic risk in sporadic parkinson disease
     Lasse Pihlstrøm, Cornelis Blauwendraat, Chiara Cappelletti, Victoria Berge‐Seidl, Margrete Langmyhr, Sandra Pilar Henriksen, Wilma D. J. van de Berg, Jesse Raphael Gibbs, Mark R. Cookson, Andrew Singleton et al. · 2018 · Annals of Neurology